B. Endress

Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1).

M. Fromm, R. Maas, M. Mieth, 2012, Journal of molecular and cellular cardiology.

Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1)

F. Müller, M. Fromm, R. Maas, 2013, Amino Acids.

Interaction of beta‐blockers with the renal uptake transporter OCT2

H. Glaeser, J. König, I. Bachmakov, 2009, Diabetes, obesity & metabolism.

Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1)

F. Müller, M. Fromm, R. Maas, 2013, Amino Acids.

Characterization of β‐adrenoceptor antagonists as substrates and inhibitors of the drug transporter P‐glycoprotein 1

M. Fromm, U. Werner, D. Augé, 2006 .

Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein.

M. Fromm, U. Werner, D. Augé, 2006, Fundamental & clinical pharmacology.